TPTX » Topics » Item 9.01 Financial Statements and Exhibits.

This excerpt taken from the TPTX 8-K filed Oct 7, 2009.

Item 9.01 Financial Statements and Exhibits.

 

(d)

 

Exhibits.

 

 

Filed

 

Exhibit

 

Here

Incorporated by Reference

No.

Exhibit Description

with

Form

File No.

Exhibit

Filing Date

Filed By

4.7

Form of Stock Certificate for Raptor

X

 

 

 

 

 

 

 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 


 

 

 

RAPTOR PHARMACEUTICAL CORP.


Date: October 7, 2009

 

 


By: /s/ Kim R. Tsuchimoto

 

 

Name:

Title:

Kim R. Tsuchimoto
Chief Financial Officer, Treasurer and Secretary

 

 

 

 

 

Exhibit Index

 

 

Filed

 

Exhibit

 

Here

Incorporated by Reference

No.

Exhibit Description

with

Form

File No.

Exhibit

Filing Date

Filed By

4.7

Form of Stock Certificate for Raptor

X

 

 

 

 

 

 

 

 

 

 

This excerpt taken from the TPTX 8-K filed Jul 31, 2009.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

99.1    Press Release titled “TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction.”


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: July 30, 2009    
  By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and
    Chief Financial Officer


INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

99.1   Press Release titled “TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction.”
This excerpt taken from the TPTX 8-K filed Jul 28, 2009.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

  2.1

  Agreement and Plan of Merger and Reorganization, dated July 27, 2009, by and among Raptor Pharmaceuticals Corp., TorreyPines Therapeutics, Inc., a Delaware corporation, and ECP Acquisition, Inc., a Delaware corporation. *

  4.1

  Rights Agreement Amendment, dated as of July 27, 2009, to the Rights Agreement dated May 13, 2005 between TorreyPines and American Stock Transfer and Trust Company (replacing The Nevada Agency and Trust Company)

10.1

  Second Amended and Restated Employment by and between Evelyn Graham and TPTX, Inc. dated July 27, 2009

10.2

  Second Amended and Restated Employment by and between Craig Johnson and TPTX, Inc. dated July 27, 2009

10.3

  Second Amended and Restated Employment by and between Paul Schneider and TPTX, Inc. dated July 27, 2009

99.1

  Press Release titled “Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement.”

99.2

  Form of Raptor Voting Agreement

99.3

  Form of TorreyPines Voting Agreement

 

*   Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. TorreyPines undertakes to furnish supplemental copies of any of the omitted schedules upon request by the Securities and Exchange Commission.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: July 28, 2009    
  By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and Chief Financial Officer

 


INDEX TO EXHIBITS

 

Exhibit
Number

  

Description

  2.1

   Agreement and Plan of Merger and Reorganization, dated July 27, 2009, by and among Raptor Pharmaceuticals Corp., TorreyPines Therapeutics, Inc., a Delaware corporation, and ECP Acquisition, Inc., a Delaware corporation. *

  4.1

   Rights Agreement Amendment, dated as of July 27, 2009, to the Rights Agreement dated May 13, 2005 between TorreyPines and American Stock Transfer and Trust Company (replacing The Nevada Agency and Trust Company)

10.1

   Second Amended and Restated Employment by and between Evelyn Graham and TPTX, Inc. dated July 27, 2009

10.2

   Second Amended and Restated Employment by and between Craig Johnson and TPTX, Inc. dated July 27, 2009

10.3

   Second Amended and Restated Employment by and between Paul Schneider and TPTX, Inc. dated July 27, 2009

99.1

   Press Release titled “Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement.”

99.2

   Form of Raptor Voting Agreement

99.3

   Form of TorreyPines Voting Agreement

 

* Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. TorreyPines undertakes to furnish supplemental copies of any of the omitted schedules upon request by the Securities and Exchange Commission.
This excerpt taken from the TPTX 8-K filed Jul 22, 2009.

Item 9.01. Financial Statements and Exhibits

(d) The following exhibit is furnished herewith:

 

99.1    Press release dated July 20, 2009


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        TORREYPINES THERAPEUTICS, INC.
Date: July 22, 2009      
    By:  

/s/    Craig Johnson

    Name:   Craig Johnson
    Title:   Vice President, Finance and Chief Financial Officer


INDEX TO EXHIBITS

 

Exhibit
Number

  

Description

99.1    Press release dated July 20, 2009
This excerpt taken from the TPTX 8-K filed Nov 26, 2008.

Item 9.01.     Financial Statements and Exhibits

(d) The following exhibit is furnished herewith:

99.1     Press release dated November 25, 2008


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.
Date: November 26, 2008    
    By:   /s/ Craig Johnson
      Name:   Craig Johnson
      Title:  

Vice President, Finance and

Chief Financial Officer


INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

99.1   Press release dated November 25, 2008
This excerpt taken from the TPTX 8-K filed Nov 10, 2008.

Item 9.01. Financial Statements and Exhibits

(d) The following exhibit is furnished herewith:

 

  99.1     Press release dated November 10, 2008


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     TORREYPINES THERAPEUTICS, INC.
Date: November 10, 2008    By:  

/s/    Craig Johnson

   Name:   Craig Johnson
   Title:   Vice President, Finance and
     Chief Financial Officer


INDEX TO EXHIBITS

 

Exhibit
Number

  

Description

99.1    Press release dated November 10, 2008
This excerpt taken from the TPTX 8-K filed Jun 23, 2008.

Item 9.01. Financial Statements and Exhibits

(d) The following exhibit is included with this Report:

 

10.1    TorreyPines Therapeutics, Inc. 2008 Employee Stock Purchase Plan and Form of Offering Document thereunder.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TORREYPINES THERAPEUTICS, INC.

 

Date: June 23, 2008

   
  By:  

 

/s/ Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and Chief Financial Officer


INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

10.1   TorreyPines Therapeutics, Inc. 2008 Employee Stock Purchase Plan and Form of Offering Document thereunder.
This excerpt taken from the TPTX 8-K filed Feb 14, 2008.

Item 9.01.              Financial Statements and Exhibits

 

(d)            The following exhibit is furnished herewith:

 

99.1                                          Press release dated February 14, 2008

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

Date:  February 14, 2008

 

 

By:

    /s/ Craig Johnson

 

Name:  Craig Johnson

 

Title:

Vice President, Finance and

 

 

 Chief Financial Officer

 

3



 

INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

 

 

 

99.1

 

Press release dated February 14, 2008

 

4


This excerpt taken from the TPTX 8-K filed Sep 25, 2007.

Item 9.01.      Financial Statements and Exhibits

 

(d)            The following exhibit is furnished herewith:

 

99.1      Press release dated September 25, 2007

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

Date: September 25, 2007

 

 

By:

/s/ Craig Johnson

 

 

Name: Craig Johnson

 

Title: Vice President, Finance and

 

           Chief Financial Officer

 

3



 

INDEX TO EXHIBITS

 

Exhibit

 

 

Number

 

Description

99.1

 

Press release dated September 25, 2007

 


This excerpt taken from the TPTX 8-K filed Dec 20, 2006.

ITEM 9.01             FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

Exhibit Number

 

 

 

Description

10.1

 

Employment Agreements by and between Neil M. Kurtz, M.D. and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

 

 

10.2

 

Employment Agreements by and between Evelyn Graham and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

 

 

10.3

 

Employment Agreements by and between Craig Johnson and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

 

5




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

Date: December 20, 2006

 

 

 

 

By:

/s/ Craig Johnson

 

 

Name: Craig Johnson

 

 

Title: Vice President, Finance and Chief Financial Officer

 

6




EXHIBIT INDEX

Exhibit
Number

 

Description

 

10.1

 

Employment Agreements by and between Neil M. Kurtz, M.D. and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

10.2

 

Employment Agreements by and between Evelyn Graham and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

10.3

 

Employment Agreements by and between Craig Johnson and TorreyPines Therapeutics, Inc. dated December 14, 2006.

 

 

 

 

7



This excerpt taken from the TPTX 8-K filed Dec 13, 2006.

ITEM 9.01             FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

Exhibit Number

 

Description

16.1

 

Letter from Eisner LLP to the Securities and Exchange Commission, dated December 13, 2006.

 

 

3




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TORREYPINES THERAPEUTICS, INC.

 

 

 

 

 

 

Date: December 13, 2006

 

 

 

 

By:

/s/ Craig Johnson

 

 

 

Name:

Craig Johnson

 

 

Title:

Vice President, Finance and

 

 

 

 Chief Financial Officer

 

4




EXHIBIT INDEX

Exhibit Number

 

Description

16.1

 

Letter from Eisner LLP to the Securities and Exchange Commission, dated December 13, 2006.

 

5



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki